Changes in 12-Year First-Line Eradication Rate of Helicobacter pylori Based on Triple Therapy with Proton Pump Inhibitor, Amoxicillin and Clarithromycin
Open Access
- 1 January 2010
- journal article
- Published by The Society for Free Radical Research Japan in Journal of Clinical Biochemistry and Nutrition
- Vol. 47 (1), 53-58
- https://doi.org/10.3164/jcbn.10-10
Abstract
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societiesKeywords
This publication has 31 references indexed in Scilit:
- Sitafloxacin and Garenoxacin May Overcome the Antibiotic Resistance of Helicobacter pylori with gyrA MutationAntimicrobial Agents and Chemotherapy, 2009
- Quinolone-Based Third-Line Therapy for Helicobacter pylori EradicationJournal of Clinical Biochemistry and Nutrition, 2009
- Effect of CYP2C19 Genetic Polymorphisms on the Efficacy of Proton Pump Inhibitor‐Based Triple Therapy for Helicobacter pylori Eradication: A Meta‐AnalysisHelicobacter, 2008
- H pylori eradication: A randomized prospective study of triple therapy with or without ecabet sodiumWorld Journal of Gastroenterology, 2008
- Changing Antimicrobial Susceptibility Epidemiology of Helicobacter pylori Strains in Japan between 2002 and 2005Journal of Clinical Microbiology, 2007
- Evidence that the Degree and Duration of Acid Suppression are Related to Helicobacter pylori Eradication by Triple TherapyHelicobacter, 2007
- Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus ReportGut, 2007
- Rabeprazole‐based eradication therapy for Helicobacter pylori: a large‐scale study in JapanAlimentary Pharmacology & Therapeutics, 2007
- Helicobacter pylori: present status and future prospects in JapanThe Esophagus, 2007
- The Effectiveness of Packaged Medicine in Eradication Therapy of Helicobacter pylori in JapanJournal of Clinical Biochemistry and Nutrition, 2006